Resource Use and Cost of Subcutaneous Nerve Stimulation Versus Optimized Medical Management in Patients With Failed Back Surgery Syndrome: An Analysis of the SubQStim Study.
Colin GreenSam S EldabeRod S TaylorMehdi ZahraSimon EggingtonPublished in: Neuromodulation : journal of the International Neuromodulation Society (2021)
Subcutaneous nerve field stimulation has the potential to offset the initial costs of the device by reducing analgesic medication and the number of healthcare visits in FBSS patients, alongside potential gains in health-related quality of life. There remains uncertainty in long-term costs and cost-effectiveness of stimulation and longer-term follow-up analyses are needed.
Keyphrases
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- minimally invasive
- human health
- prognostic factors
- emergency department
- coronary artery bypass
- neuropathic pain
- percutaneous coronary intervention
- climate change
- coronary artery disease
- anti inflammatory
- risk assessment
- patient reported outcomes
- acute coronary syndrome
- adverse drug
- spinal cord injury
- gestational age
- social media